India  

At Rs 700-Rs 1,500, price of Covid vaccine in India’s private sector among costliest

IndiaTimes Sunday, 9 May 2021
From Rs 250, the cost of vaccines in the private sector has shot up by up to six times. It now ranges from Rs 700-900 for Covishield manufactured by the Serum Institute of India (SII) and Rs 1,250-1,500 for Covaxin manufactured by Bharat Biotech (BB).
0
shares
ShareTweetSavePostSend
 
Video Credit: ANI - Published
News video: Switzerland, India part of solution against COVID war: Swiss Envoy

Switzerland, India part of solution against COVID war: Swiss Envoy 01:32

Speaking on COVID situation in India, Dr. Ralf Heckner, Ambassador of Switzerland to India on May 07 said, "Fact that Switzerland relief package arrived today and tomorrow we will have the first of several relief packages of the private sector shows that we are cooperating very concretely." "Crisis...

You Might Like


💡 newsR Knowledge: Other News Mentions

COVID-19 COVID-19 Disease caused by severe acute respiratory syndrome coronavirus 2

WHO accepts Bharat Biotech's Expression of Interest for Covaxin emergency use listing

The World Health Organisation (WHO) has accepted Bharat Biotech’s expression of interest (EoI) for the emergency use listing (EUL) of India's first..
IndiaTimes
Portugal's COVID recovery plan is first to receive Brussels' approval [Video]

Portugal's COVID recovery plan is first to receive Brussels' approval

The funds are expected to start flowing in July.

Credit: euronews (in English)    Duration: 02:14Published

This is the BEST Indian city to live in during COVID-19, says study

This Indian city offers the best medical infrastructure, open area and low population density, crucial livability parameters during COVID-19.
DNA
PM Modi says focus must be on repairing and preparing the health infrastructure| Oneindia News [Video]

PM Modi says focus must be on repairing and preparing the health infrastructure| Oneindia News

Prime Minister Narendra Modi on Wednesday said the focus must be on repairing and preparing the health infrastructure as well as the economy for future challenges. With most states recording a drop in Covid cases and deaths, restrictions put in place to break the chain of transmission are being gradually lifted. Union Health Minister Dr Harsh Vardhan tweeted Wednesday that The decision to increase the gap between two doses of the Covishield vaccine was transparent and based on scientific data. #PMModi #Covid19 #ChiragPaswan

Credit: Oneindia    Duration: 02:36Published

Serum Institute of India Serum Institute of India Indian biotechnology and biopharmaceuticals company

SII, Bharat Biotech seek hike in government price for Covid vaccines

Serum Institute of India (SII) and Bharat Biotech (BB) are seeking higher prices for Covid-19 vaccines from the Centre amid concerns that the cost of Covishield..
IndiaTimes

COVID-19: Serum Institute's Novavax vaccine shows 90% overall efficacy

Novavax in collaboration with Indian drug manufacturer Serum Institute of India is manufacturing these vaccines for India and low-income countries.
DNA

Covid-19: Novavax set for India launch with Serum Institute of India as manufacturing partner

The uncertain path to authorisation in the US for Novavax despite passing the efficacy test with an impressive score of 90.4% might see India emerge as a major..
IndiaTimes
Novavax vaccine over 90% effective in U.S. trial [Video]

Novavax vaccine over 90% effective in U.S. trial

Novavax Inc on Monday reported late-stage data from its U.S.-based clinical trial showing its vaccine is more than 90% effective against COVID-19 across a variety of variants of the virus. Emer McCarthy reports.

Credit: Reuters - Politics    Duration: 01:41Published
Lucknow man files complaint against Adar Poonawalla for 'no antibodies' despite jab | Oneindia News [Video]

Lucknow man files complaint against Adar Poonawalla for 'no antibodies' despite jab | Oneindia News

A man in Lucknow has filed a complaint against Serum Institute of India CEO Adar Poonawalla and others, alleging that he did not develop antibodies despite taking a Covishield dose. The complaint has been filed at Aashiana police station in Lucknow. Meanwhile, the complainant has threatened to move court if an FIR is not registered against the people mentioned in his complaint. #AdarPoonawalla #Covidshield #SerumInstitute

Credit: Oneindia    Duration: 01:48Published

Covaxin Covaxin Vaccine against COVID-19

Bharat Biotech, WHO pre-submission meeting on June 23: WHO

Hyderabad-based Bharat Biotech's pre-submission meeting has been scheduled on June 23 for evaluation of the World Health Organisation (WHO)'s Emergency Use..
IndiaTimes
New born calf serum in Covaxin? Health Ministry corrects facts | Oneindia News [Video]

New born calf serum in Covaxin? Health Ministry corrects facts | Oneindia News

Several social media users including Congress members have been sharing an RTI report that details the "ingredients" used in the India-made Covid-19 vaccine. #Covaxin #CalfSerum #FactCheck

Credit: Oneindia    Duration: 02:00Published

Bharat Biotech Bharat Biotech Indian biotechnology company and vaccine manufacturer

Fact Check: No newborn calf serum in Covaxin, Health Ministry and Bharat Biotech confirm

The final vaccine does not contain newborn calf serum at all as the calf serum is not an ingredient of the final vaccine product, Health Ministry said
DNA

Covaxin does not contain newborn calf serum: Centre busts myths

The indigenously developed Covaxin does not contain newborn calf serum, clarified Centre on Wednesday. The statement came in response to some social media posts..
IndiaTimes

Oxford–AstraZeneca COVID-19 vaccine Oxford–AstraZeneca COVID-19 vaccine Vaccine against COVID-19

Covishield dose gap: Dr Harsh Vardhan says decision based on scientific data | Oneindia News [Video]

Covishield dose gap: Dr Harsh Vardhan says decision based on scientific data | Oneindia News

Union Health Minister Dr Harsh Vardhan tweeted Wednesday that The decision to increase the gap between two doses of the Covishield vaccine was transparent and based on scientific data. He wrote, 'The decision to increase the gap between administering two doses of Covishield has been taken in a transparent manner based on scientific data. India has a robust mechanism to evaluate data. It is unfortunate that such an important issue is being politicised!" #CovishieldDoseGap #Covishield #Covid19

Credit: Oneindia    Duration: 02:06Published

Covid-19: Decision to extend gap between doses was unanimous, says govt

The decision to increase the gap between two doses of Covishield vaccine from 4-6 weeks to 12-16 weeks was “unanimous” and based on studies that showed that..
IndiaTimes

Related videos from verified sources

India: Construction sector re-opens after lockdown| Covid-19 | Oneindia News [Video]

India: Construction sector re-opens after lockdown| Covid-19 | Oneindia News

Delhi has started easing restrictions. The construction sector was one of the first to open. Construction workers who have been left jobless hope to return to their jobs. #India #ConstructionCentre..

Credit: Oneindia     Duration: 03:16Published
Vaccine prices at private hospitals capped by centre| Covidshield| Covaxin| Sputnik V| Oneindia News [Video]

Vaccine prices at private hospitals capped by centre| Covidshield| Covaxin| Sputnik V| Oneindia News

A day after Prime Minister Narendra Modi capped the service charge of vaccines administered by private hospitals at Rs 150, the Centre on Tuesday fixed the maximum price for Covid vaccines to be given..

Credit: Oneindia     Duration: 02:04Published
Covid-19: Finance Ministry says, 'new vaccine plan to cost ₹ 50,000 Cr'| Oneindia News [Video]

Covid-19: Finance Ministry says, 'new vaccine plan to cost ₹ 50,000 Cr'| Oneindia News

Maharashtra Chief Minister Uddhav Thackeray met Prime Minister Narendra Modi in Delhi on Tuesday morning. A day after Prime Minister Narendra Modi announced that the Centre is taking back..

Credit: Oneindia     Duration: 02:19Published

Related news from verified sources

Not cancelling existing online bookings for 2nd Covishield dose: Govt

The Union health ministry on Sunday clarified that all those people who had already booked online appointments for the second dose of Covishield vaccine will be...
IndiaTimes

New Covishield schedule of 12-16 wks in CoWin

The government has reconfigured the CoWin platform to reflect the new dosing schedule of 12-16 weeks for Covishield as against the previous scheme where...
IndiaTimes Also reported by •Zee News

US supplies of vaccine components to India to enable manufacturing of two crore doses of Covishield

The US on Wednesday said the vaccine components it has supplied to India this week will enable the manufacturing of two crore doses of the Covishield vaccine...
IndiaTimes